BRANDI FINCHER: Open Payments
NPI 1811299753 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 9 payments from 7 companies in 2025. Trend: 2023 $283 · 2024 $344 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $125 |
| Kite Pharma, Inc. | 1 | $92 |
| Janssen Biotech, Inc. | 1 | $86 |
| Celgene Corporation | 1 | $75 |
| ABBVIE INC. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Terumo BCT, Inc. | 1 | $14 |
Products named: Niktimvo, Yescarta, TALVEY, BREYANZI, EPKINLY, NINLARO, SPECTRA OPTIA.
Industry payments across LA — which companies pay providers there.
